Production (Stage)
Opus Genetics, Inc.
IRD
$1.04
$0.044.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.62M | -57.53M | -27.19M | -14.11M | -11.30M |
| Total Depreciation and Amortization | 23.00K | 10.00K | 3.00K | 4.00K | 5.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.34M | 28.86M | 3.27M | 4.34M | 4.96M |
| Change in Net Operating Assets | 2.40M | 3.09M | 10.33M | -1.70M | 3.16M |
| Cash from Operations | -28.85M | -25.58M | -13.59M | -11.46M | -3.18M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.21M | 1.21M | -- | -- | -- |
| Cash from Investing | 1.21M | 1.21M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.41M | 4.50M | 8.27M | 13.30M | 11.74M |
| Repurchase of Common Stock | -73.00K | -79.00K | -42.00K | -42.00K | -42.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.94M | -232.00K | -358.00K | -361.00K | -339.00K |
| Cash from Financing | 22.28M | 4.19M | 7.87M | 12.90M | 11.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.37M | -20.18M | -5.72M | 1.43M | 8.17M |